A new study by a team at Tohoku University, published in Chemical Engineering Journal, has shown that more isn't always ...

Got a complex task for AI? You’ll get better results by breaking it down first. This prompt will get you started.

New solutions include customized reagents that scale from bench to clinical trials, industrialized lentiviral vector ...

The company has a flexible approach that makes use of its antibody platform downstream process where appropriate, and augments its development process with high-throughput (HT) approaches to ...

Novel molecular formats - Fc-fusion proteins, bispecific antibodies, and Fab fragments - are driving therapeutic ...